Mazor Robotics: Mazor posts Q3 miss, wins FDA nod for Mazor X Stealth edition

Mazor Robotics (NSDQ:MZOR) today released third quarter earnings that narrowly missed loss-per-share expectations on Wall Street, and announced that it won FDA clearance for its Mazor X Stealth edition. The Caesarea, Israel-based company posted losses of $16.9 million, or 32¢ per share, on sales of approximately $10.1 million for the three months ended September 30, [...]The post Mazor posts Q3 miss, wins FDA nod for Mazor X Stealth edition appeared first on MassDevice.